Answer
Efavirenz/emtricitabine/tenofovir disoproxil Glenmark should not be used during breastfeeding because efavirenz, emtricitabine and tenofovir enter human milk, infant effects are insufficiently understood and risk cannot be excluded; women with HIV are also advised not to breastfeed to avoid transmitting HIV.
Sources for this answer
- Efavirenz/Emtricitabine/Tenofovir disoproxil Glenmark 600 mg/ 200 mg/245 mg film-coated tabletsGlenmark Pharmaceuticals Europe Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 5Document updated
Sources checked